Primary Site >> Stomach Cancer
Gene >> ABCC2
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Pharmacogenetics of stomach cancer. PMID: 12914384 |
Ref: Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP. PMID: 15771954 |
Ref: The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells. PMID: 19513507 |
Ref: The effect of radixin knockdown on the expression and efflux function of MRP2 in SGC-7901 cells. PMID: 22469515 |
Ref: Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma. PMID: 26985715 Ref: ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients. PMID: 27487151 |
Ref: DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance. PMID: 28677116 |
Ref: Combination of TNM staging and pathway based risk score models in patients with gastric cancer. PMID: 29231991 Ref: Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxiatelangiectasia mutated and nuclear factorkappaB pathways in gastric cancer cells. PMID: 30106453 Ref: Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells. PMID: 30221675 |